Published in Psychosomatics on June 17, 1993
Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Aliment Pharmacol Ther (2012) 1.64
Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci (2000) 1.50
Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol (2007) 1.26
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2013) 1.20
Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management. J Neurogastroenterol Motil (2012) 1.12
Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med (2003) 1.10
Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol (2011) 1.09
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol (2012) 1.03
Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes. J Neurogastroenterol Motil (2010) 1.01
Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol (2011) 1.01
The development and psychometric validation of the central sensitization inventory. Pain Pract (2011) 1.01
Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J Neurogastroenterol Motil (2012) 0.99
The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes (2014) 0.96
Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. Eur J Epidemiol (2007) 0.94
Psychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based study. BMC Med (2005) 0.92
The bladder-brain connection: putative role of corticotropin-releasing factor. Nat Rev Urol (2010) 0.92
Interleukin-6 modulates colonic transepithelial ion transport in the stress-sensitive wistar kyoto rat. Front Pharmacol (2012) 0.87
Trauma and the gut: interactions between stressful experience and intestinal function. Gut (1997) 0.87
Irritable bowel syndrome: relations with functional, mental, and somatoform disorders. World J Gastroenterol (2014) 0.86
Psychologic Therapies for Irritable Bowel Syndrome. Curr Treat Options Gastroenterol (2001) 0.82
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis (2013) 0.82
Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. Am J Gastroenterol (2015) 0.80
Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon. World J Gastroenterol (2007) 0.80
Psychological features in patients with and without irritable bowel syndrome: A case-control study using Symptom Checklist-90-Revised. Indian J Psychiatry (2015) 0.79
[Functional gastrointestinal disorders]. Wien Med Wochenschr (2006) 0.77
Evaluation of psychological aspects among subtypes of irritable bowel syndrome. Indian J Psychol Med (2012) 0.76
Brain-gut interactions. West J Med (1994) 0.75
Cross-cultural adaptation and validity of the Spanish central sensitization inventory. Springerplus (2016) 0.75
Evidence of overlapping genetic diathesis of panic attacks and gastrointestinal disorders in a sample of male twin pairs. Twin Res Hum Genet (2011) 0.75
New insights into the understanding of gastrointestinal dysmotility. Drug Target Insights (2007) 0.75
Serotonin-Related Gene Variants in Patients with Irritable Bowel Syndrome and Depressive or Anxiety Disorders. Gastroenterol Res Pract (2017) 0.75
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study. J Neurogastroenterol Motil (2017) 0.75
The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry (1999) 4.23
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res (1979) 2.45
A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry (2000) 2.39
Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry (1978) 1.88
Procedural and methodological issues in telepsychiatry research and program development. Psychiatr Serv (2000) 1.78
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Acetylator status and response to phenelzine in depressed patients. Lancet (1973) 1.67
The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med (2002) 1.63
Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg (1999) 1.55
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry (1989) 1.53
Measurement of the nucleon strange-antistrange asymmetry at next-to-leading order in QCD from NuTeV Dimuon data. Phys Rev Lett (2007) 1.38
Event excess in the MiniBooNE search for ¯νμ→¯νe oscillations. Phys Rev Lett (2010) 1.37
CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. Am J Psychiatry (1993) 1.36
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33
Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology (1999) 1.29
Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry (1988) 1.28
Cocaine-induced psychosis. J Clin Psychiatry (1991) 1.24
Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol (1993) 1.23
Liver transplantation in older patients. N Engl J Med (1987) 1.20
Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry (1986) 1.18
The effects of pregnancy on preexisting panic disorder. J Clin Psychiatry (1992) 1.13
Update on anxiety disorders. Arch Intern Med (1991) 1.09
Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry (1986) 1.09
Adenoma of the common bile duct: endoscopic diagnosis and resection. Gastrointest Endosc (1992) 1.09
Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry (1980) 1.07
Effects of vasopressin on human memory functions. Science (1981) 1.07
Treatment of panic disorder in the general medical setting. J Psychosom Res (1998) 1.06
Biological aspects of panic disorder. Am J Psychiatry (1986) 1.04
Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry (1979) 1.03
Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology (2000) 1.03
Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry (1995) 1.02
Electroconvulsive therapy and cardiac pacemakers. Psychosomatics (1974) 0.99
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc (2005) 0.98
Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry (1995) 0.98
Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry (1996) 0.98
Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety (1999) 0.98
Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug. Cancer Res (1986) 0.97
Ectomesenchymal chondromyxoid tumor of the anterior tongue: a report of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.97
Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry (1997) 0.94
Kindling and carbamazepine in affective illness. J Nerv Ment Dis (1982) 0.94
A brief scale for assessing patients' satisfaction with care in outpatient psychiatric services. Psychiatr Serv (2001) 0.94
Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry (1995) 0.93
Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict (2001) 0.93
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry (1983) 0.93
Antidepressants in panic disorder and agoraphobia. J Affect Disord (1988) 0.92
Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry (1995) 0.92
CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry (1990) 0.91
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry (1997) 0.91
Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation (2002) 0.91
Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry (1994) 0.91
Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter". Arch Gen Psychiatry (1981) 0.90
Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacol Bull (1989) 0.90
Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am (2000) 0.89
The "atypical" clinical picture of adolescent mania. Am J Psychiatry (1982) 0.89
Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull (1984) 0.89
A case of camptocormia occurring in psychotherapy. J Nerv Ment Dis (1976) 0.89
CSF somatostatin in affective illness. Arch Gen Psychiatry (1983) 0.89
Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry (1993) 0.89
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry (1987) 0.89
Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol Psychiatry (1996) 0.88
Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness. Arch Gen Psychiatry (1986) 0.88
Leiomyosarcoma metastatic to the oral region. Report of three cases. Oral Surg Oral Med Oral Pathol (1993) 0.88
Improvements in hepatic parenchymal transection for living related liver donor. Transplant Proc (2005) 0.87
Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells. Cancer Res (1987) 0.87
A community-based public-academic liaison program. Am J Psychiatry (1994) 0.87
Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patients. Neurology (1979) 0.86
Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder. Lancet (1979) 0.85
Dopamine-beta-hydroxylase in the cerebrospinal fluid: relationship to disulfiram-induced psychosis. Biol Psychiatry (1979) 0.85
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am J Psychiatry (1981) 0.85
Early family experiences of women with bulimia and depression. Arch Psychiatr Nurs (1990) 0.84
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry (1988) 0.84
Modulation of the late asthmatic response by antigen-specific immunoglobulin G in an animal model. Am Rev Respir Dis (1984) 0.84
Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry (1998) 0.84
Meta-analysis of prognostic factors for amputation following surgical repair of lower extremity vascular trauma. Br J Surg (2015) 0.83
Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant Proc (1987) 0.83
Obsessive-compulsive symptoms in a patient with multiple sclerosis. J Nerv Ment Dis (1989) 0.83
Phenelzine treatment of panic disorder: lack of effect on pyridoxal phosphate levels. J Clin Psychopharmacol (1989) 0.83
Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol (1978) 0.83
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. Transplant Proc (2001) 0.82
Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry (1999) 0.82
Brain MRI in obsessive-compulsive disorder. Psychiatry Res (1991) 0.82
Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord (1989) 0.82
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Transplantation (2001) 0.82
CSF dopamine beta-hydroxylase in schizophrenia. Arch Gen Psychiatry (1983) 0.82
Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. Life Sci (1982) 0.81
Cocaine abuse among schizophrenic patients. Am J Psychiatry (1990) 0.81
Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiatry (1993) 0.81
The neurobiology of some dimensions of personality. Int Rev Neurobiol (1984) 0.81
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc (2001) 0.81
Coexisting depression and anxiety: special diagnostic and treatment issues. J Clin Psychiatry (1991) 0.81
Panic disorder. Pathophysiology and drug treatment. Drugs (1995) 0.81
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry (1995) 0.81
Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab (1983) 0.81
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biol Psychiatry (1991) 0.80